Orthofix director granted 14,965 deferred stock units
Orthofix Medical Inc. director Jason Hannon reported receiving an award of 14,965 deferred stock units of common stock on June 10, 2026.
Rhea-AI Filing Summary
Orthofix Medical Inc. director Jason Hannon reported receiving an award of 14,965 deferred stock units of common stock on June 10, 2026. These units vest in full on the first anniversary of the grant date, as long as he continues serving the company.
Each deferred stock unit represents a contingent right to receive one share of Orthofix common stock, which will be delivered within 45 days after his service with the company ends. Following this grant, Hannon directly holds 87,662 deferred stock units and shares, including 63,631 previously reported deferred stock units and 2,103 shares acquired through Orthofix's Stock Purchase Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 14,965 shares
Grant/Award
1 txn
Insider
Hannon Jason
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 14,965 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 87,662 shares (Direct)
Footnotes (2)
- F1. Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
- F2. Includes 63,631 previously reported deferred stock units and an aggregate of 2,103 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025 and 4/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).
Key Figures
Deferred stock unit grant: 14,965 units
Total holdings after award: 87,662 shares/units
Previously reported deferred units: 63,631 units
+4 more
7 metrics
Deferred stock unit grant
14,965 units
Awarded June 10, 2026 to director Jason Hannon
Total holdings after award
87,662 shares/units
Common stock and deferred stock units held directly after grant
Previously reported deferred units
63,631 units
Deferred stock units reported before the June 10, 2026 award
Stock Purchase Plan shares
2,103 shares
Acquired under Orthofix's SPP on 10/31/2025 and 4/30/2026
Vesting schedule
1-year cliff
Award vests in full on first anniversary of grant date
Settlement timing
Within 45 days
Conversion into common stock after termination of service
Grant price
$0.00 per unit
Compensation award, no cash paid by the director
Key Terms
deferred stock units, Orthofix's Stock Purchase Plan, Rule 16b-3(b)(5), Section 16(b)
4 terms
deferred stock units financial
"Represents an award of deferred stock units that vest in full on the first anniversary of the grant date"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Orthofix's Stock Purchase Plan financial
"Includes 63,631 previously reported deferred stock units and an aggregate of 2,103 shares acquired under Orthofix's Stock Purchase Plan"
Rule 16b-3(b)(5) regulatory
"Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5)"
Section 16(b) regulatory
"share acquisitions under the plan are exempt from Section 16(b)"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
FAQ
What insider transaction did Orthofix (OFIX) director Jason Hannon report?
Jason Hannon reported an acquisition of 14,965 deferred stock units of Orthofix common stock as a compensation award. The grant is priced at $0.00 per unit and increases his total direct holdings, including prior deferred units and stock purchase plan shares.
When do Jason Hannon’s new Orthofix (OFIX) deferred stock units vest?
The 14,965 deferred stock units vest in full on the first anniversary of the June 10, 2026 grant date. Vesting is conditioned on Hannon’s continued service with Orthofix through that date, making it a standard time-based director compensation award.
How and when will Jason Hannon’s Orthofix (OFIX) deferred stock units settle?
Each deferred stock unit converts into one share of Orthofix common stock. The vested units will settle and convert into shares within 45 days after Hannon’s termination of service with Orthofix, deferring share delivery until he leaves the board.
What are Jason Hannon’s total Orthofix (OFIX) holdings after this award?
After the 14,965-unit award, Hannon directly holds 87,662 deferred stock units and shares. This total includes 63,631 previously reported deferred stock units and 2,103 shares accumulated through Orthofix’s Stock Purchase Plan on 10/31/2025 and 4/30/2026.
What is Orthofix’s Stock Purchase Plan mentioned in the Form 4 for OFIX?
Orthofix’s Stock Purchase Plan is described as a “Stock Purchase Plan” under Rule 16b-3(b)(5). Hannon acquired 2,103 shares under this plan on 10/31/2025 and 4/30/2026, and these acquisitions are exempt from short-swing profit rules under Section 16(b).
AI-generated analysis. How Rhea-AI works. Not financial advice.
